Search

everythinglearnresearchcommunity

for

Search:↓

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Noggin promotes skin tumors by activating certain cell signaling pathways.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Upadacitinib effectively treats severe alopecia areata and is safe.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

NEDD4 and NEDD4L help control intestinal stem cells and prevent tumors by breaking down the LGR5 receptor.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole fails.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Tideglusib helps heal wounds in older skin.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.